BioSpace News Archive

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced that management will present a corporate overview and updated clinical development plans for its lead candidates ZW25 and ZW49 at the upcoming 38th Annual J.P. Morgan Healthcare Conference

Spearhead Lodge (SHL) formally announced today that as the complexity of our world increases, they are changing to meet that need

The acquisition advances Aon’s data & analytics capabilities and further enables the firm to develop and scale digital client solutions

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq:YMAB), today announced that Dr. Claus Møller, MD, Ph.D., Chief Executive Officer of Y-mAbs Therapeutics will provide an overview and update on the company’s business at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California.

Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF) (“Harvest”), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., today announced that yesterday Harvest filed suit against Falcon International, Inc. (“Falcon”) requesting termination and rescission of the Merger Agreement (“Transaction”) and return of money Harvest paid to Falcon under the Merger Agreement.

PanAmerican Clinical Research, delivering research and patient recruitment services in South, Central, and North America, adds Mitchell Parrish and Kraig Keeter to its executive leadership team.

US Radiology Specialists announced today a new partnership with Upstate Carolina Radiology (UCR), a leading physician-owned provider of high-quality diagnostic and interventional radiology services in upstate South Carolina

Largest bi-coastal vivarium services provider in U.S. opens sixth coworking space

Dyve Biosciences, Inc. announced that longtime Pfizer Executive Chuck Harbert, Ph.D. has joined the company in the role of Chief Scientific Officer.

Data published in Journal of General Internal Medicine show that patients using Qsymia and other weight loss tools, lost at least 5% of body weight loss compared with those not using Qsymia